Early clinical - Blog Archives

Blog

Pharmacometricians can use machine learning for PK/PD modeling to help them characterize the safety and…

Blog

February 28, 2025 For the past couple of decades, leading American institutions, pharmaceutical and biotechnology…

Blog

February 7, 2025A key drug development safety consideration is whether the drug candidate will interact…

Blog

January 10, 2025 Friedreich’s Ataxia (FA) is a rare, genetic, and progressive neurodegenerative disorder. A…

Blog

December 5, 2024 What is a “cell therapy”? Nearly every recent oncology clinical conference has…

Becca BucciDecember 5, 2024

Blog

November 22, 2024 In drug development, early strategic planning is crucial to minimizing risks, optimizing…

Blog

On October 30, 2024, we hosted our Pinnacle 21 Enterprise (P21E) User Group Meeting (UGM)…

Blog

A symbiosis between a modeler and a trialist is often required to develop a model-informed…

Early clinical – Blog